News

Pharmassist is funded by “Competitiveness, Entrepreneurship and Innovation” (EPAnEK) for the development of innovative technologies

Pharmassist is funded by the “Competitiveness, Entrepreneurship and Innovation” (EPAnEK) Operational Program for the development of innovative technologies regarding the detection of predictive cancer biomarkers by liquid biopsy approach. Pharmassist’s objective is the development and commercialization of in-vitro diagnostics, establishing the liquid biopsy into clinical practice. In this project, namely CANCER blood scan,...MORE

Pharmassist Ltd moved at its own premises in Athens

On the verge of celebrating its 20th anniversary, Pharmassist has moved to its privately owned, state-of-the-art premises, which will accommodate its future growth.

The new headquarters are located in Nea Ionia, at the business hub proximate to the OAKA stadium (Olympic Athletic Center of Athens "Spiros Louis").

The building extends to over 1200 square meters and its multi-level structure hosts each department to...MORE

Pharmassist Ltd is now a certified organisation for carrying out R&D activities by the French Ministry of Higher Education and Research

Pharmassist is a leading full service CRO in Greece having handled with sucess numerous regulatory activities and Clinical Trials for more than 100 active local and multinational companies. As an accreditation of excellence for carrying out  R&D acctivities for the account of private companies, Pharmassist  was approved by the Ministry of Higher Education and Research. The company has the capacity to undertake demanding...MORE